Connect the Dots

Event

Accutane lawsuits in New Jersey

Mass-tort suits against Roche over Accutane in New Jersey; many claimed bowel disease rather than birth defects. The record opened here covers the bowel-disease suits.

9 links, 1 backed by primary records

Play the story Explore connections On the map ›

Dates
2005 – 1 Aug 2018
Place
New Jersey

Connections 9

involved

  • Hoffmann-La Roche defendant; says there is no reliable scientific evidence that Accutane causes inflammatory bowel disease According to Hoffmann-La Roche Scholarship & press 1
  • Hoffmann-La Roche first verdict, 2007 (failure to warn; no consumer fraud), vacated on appeal for erroneous evidentiary rulings Scholarship & press 2
  • Hoffmann-La Roche retrial verdict, 2010, reversed by the Appellate Division as time-barred Scholarship & press 2
  • Hoffmann-La Roche the New Jersey Supreme Court reinstated the $25 million verdict in January 2017 Scholarship & press 3
  • Hoffmann-La Roche the Appellate Division vacated the verdict again on 2 May 2017, apparently heading for a third trial, a law-firm blog says; we did not find what followed Scholarship & press 2
  • Accutane (isotretinoin) the drug at issue Scholarship & press 4
  • Hoffmann-La Roche 532 claims were before the New Jersey Supreme Court in 2018 Scholarship & press 5
  • Supreme Court of New Jersey in 2018 held that the trial court properly excluded plaintiffs' experts in the Crohn's disease cases, reversing the Appellate Division Primary record 6

located in

Timeline 1 date
  1. 2005 – 1 Aug 2018 Accutane lawsuits in New Jersey
Proof 6 sources
  1. Roche to appeal $2.62 million judgment in Accutane case, Dermatology Times, 1 Jul 2007. Scholarship & press
    Notwithstanding the verdict, the cause of inflammatory bowel disease remains unknown, and there is no reliable scientific evidence that Accutane causes inflammatory bowel disease.
  2. Another Accutane Verdict Vacated in New Jersey, Drug and Device Law (law-firm blog). Scholarship & press
    The case was first tried to a jury in 2007, resulting in a verdict for the plaintiff. But the Appellate Division vacated that award and remanded for a new trial because of erroneous evidentiary rulings.
    The parties therefore tried the case again in 2010, which resulted in a larger verdict for the plaintiff. On appeal from the second verdict, the Appellate Division reversed again and held that the claims were time barred.
    The latest shoe dropped last week when the New Jersey Appellate Division vacated (again) a jury verdict in favor of an Accutane plaintiff.
  3. Court gives man $25M award in acne drug case (AP, via NJ 101.5), The Associated Press, via NJ 101.5. Scholarship & press
    New Jersey's top court has reinstated a $25 million jury award for an Alabama man who became seriously ill after taking an acne drug.
  4. Roche loses lawsuit over side effects of acne drug Accutane, PharmaTimes. Scholarship & press
    Roche has suffered a legal setback with the news that a jury in New Jersey declared that the Swiss company did not warn a plaintiff in the first of 400 lawsuits that its Accutane acne drug can cause inflammatory bowel disease.
  5. In re Accutane Litigation: opinion summary (Justia, New Jersey Supreme Court opinion summaries), Justia. Scholarship & press
    This appeal arose from 532 product-liability claims filed against Hoffmann-La Roche Inc. and Roche Laboratories Inc.
  6. In re Accutane Litigation, 234 N.J. 340 (2018), opinion of the Supreme Court of New Jersey, Supreme Court of New Jersey, 1 Aug 2018. Primary record
    Our analysis of this record leads to a clear result: the trial court properly excluded plaintiffs’ experts’ testimony.
Page history 1 change
  1. Add 55 stories, each checked against its sourcesAlibek96e92fe6

Something wrong or missing? Tell us, with a source, or edit this page.